Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma.
Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma. Cancer. 2017 Jul 15; 123(14):2642-2650.
View in:
PubMed
subject areas
Adult
Aged
Bone Neoplasms
Carcinoma
Disease Progression
Disease-Free Survival
Enzyme-Linked Immunospot Assay
Feasibility Studies
Female
Flow Cytometry
Herpesvirus 4, Human
Humans
Immunotherapy, Adoptive
Liver Neoplasms
Lung Neoplasms
Male
Middle Aged
Nasopharyngeal Neoplasms
Neoplasm Metastasis
Neoplasm Recurrence, Local
Pilot Projects
T-Lymphocytes, Cytotoxic
Young Adult
authors with profiles
Frederick Chi-Shing Wang, M.D.
Jerome Ritz, M.D.
Jochen Hanns-Martin Lorch, M.D.
Lori Julin Wirth, M.D.